6-156778847-GGGCGGCGGCGGCGGCGGC-GGGCGGCGGCGGCGGC
Variant summary
Our verdict is Benign. Variant got -17 ACMG points: 0P and 17B. BP3BP6_Very_StrongBS1BS2
The NM_001374828.1(ARID1B):βc.1191_1193delβ(p.Gly402del) variant causes a inframe deletion change. The variant allele was found at a frequency of 0.000994 in 1,395,576 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Likely benign (β β ).
Frequency
Genomes: π 0.00042 ( 0 hom., cov: 29)
Exomes π: 0.0011 ( 0 hom. )
Consequence
ARID1B
NM_001374828.1 inframe_deletion
NM_001374828.1 inframe_deletion
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 4.68
Genes affected
ARID1B (HGNC:18040): (AT-rich interaction domain 1B) This locus encodes an AT-rich DNA interacting domain-containing protein. The encoded protein is a component of the SWI/SNF chromatin remodeling complex and may play a role in cell-cycle activation. The protein encoded by this locus is similar to AT-rich interactive domain-containing protein 1A. These two proteins function as alternative, mutually exclusive ARID-subunits of the SWI/SNF complex. The associated complexes play opposing roles. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Oct 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -17 ACMG points.
BP3
Nonframeshift variant in repetitive region in NM_001374828.1
BP6
Variant 6-156778847-GGGC-G is Benign according to our data. Variant chr6-156778847-GGGC-G is described in ClinVar as [Likely_benign]. Clinvar id is 589538.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr6-156778847-GGGC-G is described in Lovd as [Likely_benign].
BS1
Variant frequency is greater than expected in population amr. gnomad4 allele frequency = 0.000419 (62/147912) while in subpopulation AMR AF= 0.00127 (19/15014). AF 95% confidence interval is 0.000829. There are 0 homozygotes in gnomad4. There are 30 alleles in male gnomad4 subpopulation. Median coverage is 29. This position pass quality control queck.
BS2
High AC in GnomAd4 at 62 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ARID1B | NM_001374828.1 | c.1191_1193del | p.Gly402del | inframe_deletion | 1/20 | ENST00000636930.2 | NP_001361757.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ARID1B | ENST00000636930.2 | c.1191_1193del | p.Gly402del | inframe_deletion | 1/20 | 2 | NM_001374828.1 | ENSP00000490491 | A2 |
Frequencies
GnomAD3 genomes AF: 0.000419 AC: 62AN: 147808Hom.: 0 Cov.: 29
GnomAD3 genomes
AF:
AC:
62
AN:
147808
Hom.:
Cov.:
29
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00506 AC: 281AN: 55508Hom.: 0 AF XY: 0.00448 AC XY: 147AN XY: 32826
GnomAD3 exomes
AF:
AC:
281
AN:
55508
Hom.:
AF XY:
AC XY:
147
AN XY:
32826
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00106 AC: 1325AN: 1247664Hom.: 0 AF XY: 0.00113 AC XY: 695AN XY: 612864
GnomAD4 exome
AF:
AC:
1325
AN:
1247664
Hom.:
AF XY:
AC XY:
695
AN XY:
612864
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000419 AC: 62AN: 147912Hom.: 0 Cov.: 29 AF XY: 0.000415 AC XY: 30AN XY: 72274
GnomAD4 genome
AF:
AC:
62
AN:
147912
Hom.:
Cov.:
29
AF XY:
AC XY:
30
AN XY:
72274
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 19, 2023 | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Mar 10, 2021 | - - |
Inborn genetic diseases Benign:1
Benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 03, 2018 | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
ARID1B-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Jun 20, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at